Responses
Regular and Young Investigator Award Abstracts
Novel Single-Agent Immunotherapies
1337 The preclinical characterization and translational research of ATG-031, a first-in-class humanized anti-CD24 antibody, for the treatment of solid tumors and hematological malignancies
Compose a Response to This Article
Other responses
No responses have been published for this article.
